✦ LIBER ✦

Soluble Fas and Fas-ligand in bladder cancer in vitro and in vivo

✍ Scribed by Frank G.E Perabo; Roland H Mattes; Andreas Wirger; Gabriel Steiner; Stefan Kamp; Doris Schmidt; Katrin Pegelow; Alexander von Ruecker; Stefan C Müller

Book ID: 117724127
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 133 KB
Volume: 6
Category: Article
ISSN: 1078-1439
DOI: 10.1016/s1078-1439(00)00130-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

SERUM SOLUBLE FAS AND SOLUBLE FAS LIGAND

SERUM SOLUBLE FAS AND SOLUBLE FAS LIGAND IN HYPERTENSION IN PREGNANCY

✍ Vellore J. Karthikeyan; Shahirose Jessani; Balu Balakrishnan; Deirdre A. Lane; S 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Soluble Fas antigen and soluble Fas liga

Soluble Fas antigen and soluble Fas ligand in early neonatal life

✍ Angeliki Sarandakou; Efthimia Protonotariou; Dimitrios Rizos; Lygeri Soubassi; A 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 187 KB

Soluble Fas (APO-1, CD95) and soluble Fa

Soluble Fas (APO-1, CD95) and soluble Fas ligand in rheumatic diseases

✍ Kazuhisa Nozawa; Nobuhiko Kayagaki; Yoshiaki Tokano; Hideo Yagita; Ko Okumura; H 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 381 KB 👁 2 views

Raised plasma soluble Fas and Fas-ligand

Raised plasma soluble Fas and Fas-ligand in alcoholic liver disease

✍ Julien Taïeb; Philippe Mathurin; Thierry Poynard; Marie Anne Gougerot-Pocidalo; 📂 Article 📅 1998 🏛 The Lancet 🌐 English ⚖ 58 KB

Soluble Fas and soluble Fas ligand level

Soluble Fas and soluble Fas ligand levels in patients with acute hepatic failure

✍ Hajime Nakae; Kyoko Narita; Shigeatsu Endo 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Elevation of soluble Fas and soluble Fas

Elevation of soluble Fas and soluble Fas ligand in reactive macrophage activation syndromes

✍ Emmenegger, U.; Zehnder, R.; Frey, U.; Reimers, A.; Spaeth, P.J.; Neftel, K.A. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 38 KB 👁 2 views

Derailed T-cell activation can give rise to life-threatening macrophage activation, the final common pathway of the different forms of reactive macrophage activation syndromes (rMAS). Besides inappropriate activation of the immune system, impaired termination of immune responses might be another mec